Blueshift Asset Management, LLC Genmab A/S Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$26.83 - $38.57 $315,950 - $454,200
-11,776 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$30.95 - $39.68 $364,467 - $467,271
11,776 New
11,776 $426,000
Q4 2021

Feb 11, 2022
SELL
$35.87 - $47.12 $463,117 - $608,366
-12,911 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$41.55 - $48.72 $536,452 - $629,023
12,911 New
12,911 $564,000

Others Institutions Holding GMAB

# of Institutions
240
Shares Held
52.6M
Call Options Held
10.2K
Put Options Held
25.5K
View Full List

About GENMAB A/S

GMAB Quotes by TradingView
  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $14.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email